✦ LIBER ✦

Interferon and thymosin combination therapy in naive patients with chronic hepatitis C: preliminary results

✍ Scribed by S. Moscarella; G. Buzzelli; R. G. Romanelli; M. Monti; C. Giannini; G. Careccia; E. M. Marrocchi; A. L. Zignegoy

Book ID: 111250151
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 405 KB
Volume: 18
Category: Article
ISSN: 0106-9543
DOI: 10.1111/j.1600-0676.1998.tb00819.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preliminary study of combination therapy

Preliminary study of combination therapy with interferon-α and zinc in chronic hepatitis C patients with genotype 1b

✍ Takeaki Nagamine; Hitoshi Takagi; Hisashi Takayama; Akira Kojima; Satoru Kakizak 📂 Article 📅 2000 🏛 Humana Press Inc 🌐 English ⚖ 135 KB

Combination therapy with interferon-α an

Combination therapy with interferon-α and ribavirin as immunomodulators in patients with chronic hepatitis C

✍ Norio Horiike; Morikazu Onji 📂 Article 📅 2003 🏛 Springer Japan 🌐 English ⚖ 132 KB

Effect of lactoferrin in patients with c

Effect of lactoferrin in patients with chronic hepatitis C: Combination therapy with interferon and ribavirin

✍ Masahiko Kaito; Motoh Iwasa; Naoki Fujita; Yoshinao Kobayashi; Yuji Kojima; Jiro 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB

Studies of Therapy with Thymosin α1 in C

Studies of Therapy with Thymosin α1 in Combination with Pegylated Interferon α2a and Ribavirin in Nonresponder Patients with Chronic Hepatitis C

✍ ROBERTO CAMERINI; ALESSIA CIANCIO; ALFONSO DE ROSA; MARIO RIZZETTO 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB

Combination of interferon induction ther

Combination of interferon induction therapy and ribavirin in chronic hepatitis C

✍ Peter Ferenci; Harald Brunner; Karin Nachbaur; Christian Datz; Michael Gschwantl 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

Limitation of combination therapy of int

Limitation of combination therapy of interferon and ribavirin for older patients with chronic hepatitis C

✍ Yoshiaki Iwasaki; Hiroshi Ikeda; Yasuyuki Araki; Toshiya Osawa; Keiji Kita; Masa 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB 👁 2 views

In contrast to the United States, Japanese patients with chronic hepatitis C currently treated with interferon are generally 10 to 15 years older. Older patients, however, tend to experience more frequent adverse events. This study was conducted to clarify the effect of patient age on the efficacy a